These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39344189)

  • 1. Association between cerebrospinal fluid chitotriosidase level and amyotrophic lateral sclerosis: a systematic review.
    Khorshidi Z; Adibi I; Ghasemi M
    Horm Mol Biol Clin Investig; 2024 Oct; ():. PubMed ID: 39344189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study.
    Steinacker P; Feneberg E; Halbgebauer S; Witzel S; Verde F; Oeckl P; Van Damme P; Gaur N; Gray E; Grosskreutz J; Jardel CG; Kachanov M; Kuhle J; Lamari F; Maceski A; Del Mar Amador M; Mayer B; Morelli C; Petri S; Poesen K; Raaphorst J; Salachas F; Silani V; Turner MR; Verbeek MM; Volk AE; Weishaupt JH; Weydt P; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 May; 22(3-4):276-286. PubMed ID: 33576252
    [No Abstract]   [Full Text] [Related]  

  • 3. Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression.
    Steinacker P; Verde F; Fang L; Feneberg E; Oeckl P; Roeber S; Anderl-Straub S; Danek A; Diehl-Schmid J; Fassbender K; Fliessbach K; Foerstl H; Giese A; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer GB; Lauer M; Pinkhardt EH; Prudlo J; Rosenbohm A; Schneider A; Schroeter ML; Tumani H; von Arnim CAF; Weishaupt J; Weydt P; Ludolph AC; Yilmazer Hanke D; Otto M;
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):239-247. PubMed ID: 29142138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF chitinase proteins in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Bampton A; Raciborska D; Talbot K; Turner MR
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1215-1220. PubMed ID: 31123140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitinases as a potential diagnostic and prognostic biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Xu A; Luo Y; Tang Y; Yang F; Gao X; Qiao G; Zhu X; Zhou J
    Neurol Sci; 2024 Jun; 45(6):2489-2503. PubMed ID: 38194198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS.
    Gagliardi D; Rizzuti M; Masrori P; Saccomanno D; Del Bo R; Sali L; Meneri M; Scarcella S; Milone I; Hersmus N; Ratti A; Ticozzi N; Silani V; Poesen K; Van Damme P; Comi GP; Corti S; Verde F
    J Neurol; 2024 Dec; 271(12):7557-7571. PubMed ID: 39340541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase.
    Oeckl P; Weydt P; Steinacker P; Anderl-Straub S; Nordin F; Volk AE; Diehl-Schmid J; Andersen PM; Kornhuber J; Danek A; Fassbender K; Fliessbach K; ; Jahn H; Lauer M; Müller K; Knehr A; Prudlo J; Schneider A; Thal DR; Yilmazer-Hanke D; Weishaupt JH; Ludolph AC; Otto M
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):4-10. PubMed ID: 30224549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Thézénas ML; Charles PD; Evetts S; Hu MT; Talbot K; Fischer R; Kessler BM; Turner MR
    Ann Neurol; 2018 Feb; 83(2):258-268. PubMed ID: 29331073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis.
    Gray E; Thompson AG; Wuu J; Pelt J; Talbot K; Benatar M; Turner MR
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1296-1306. PubMed ID: 32666680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
    Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis.
    Kläppe U; Sennfält S; Lovik A; Finn A; Bofaisal U; Zetterberg H; Blennow K; Piehl F; Kmezic I; Press R; Samuelsson K; Månberg A; Fang F; Ingre C
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):150-161. PubMed ID: 37789557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis.
    Costa J; Gromicho M; Pronto-Laborinho A; Almeida C; Gomes RA; Guerreiro ACL; Oliva A; Pinto S; de Carvalho M
    Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis.
    Agah E; Saleh F; Sanjari Moghaddam H; Saghazadeh A; Tafakhori A; Rezaei N
    Syst Rev; 2018 Dec; 7(1):237. PubMed ID: 30572951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
    Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
    Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia.
    Abu-Rumeileh S; Steinacker P; Polischi B; Mammana A; Bartoletti-Stella A; Oeckl P; Baiardi S; Zenesini C; Huss A; Cortelli P; Capellari S; Otto M; Parchi P
    Alzheimers Res Ther; 2019 Dec; 12(1):2. PubMed ID: 31892365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis.
    Zhu Y; Yang M; Li F; Li M; Xu Z; Yang F; Liu Y; Chen W; Zhang Y; Xu R
    Int J Biol Sci; 2018; 14(9):1041-1053. PubMed ID: 29989057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data-independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis.
    Dellar ER; Vendrell I; Talbot K; Kessler BM; Fischer R; Turner MR; Thompson AG
    J Neurochem; 2024 Feb; 168(2):115-127. PubMed ID: 38087504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study.
    Pagliardini V; Pagliardini S; Corrado L; Lucenti A; Panigati L; Bersano E; Servo S; Cantello R; D'Alfonso S; Mazzini L
    J Neurol Sci; 2015 Jan; 348(1-2):245-50. PubMed ID: 25563799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of
    Ng Kee Kwong KC; Gregory JM; Pal S; Chandran S; Mehta AR
    Brain Commun; 2020; 2(2):fcaa121. PubMed ID: 33094283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.